Physician profile
Patrick B Leu
NPI 1013910280
$2,774.00
in general payments reported to CMS, 2019-2025
31 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $540 · 2021: $90.53 · 2022: $255 · 2023: $172 · 2024: $438 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $375.98 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $267.84 | 2019-2025 | |
| Astellas Pharma US INC | $232.21 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $198.81 | 2019-2025 | |
| Palette Life Sciences, INC. | $178.31 | 2022 | |
| Karl Storz Endoscopy-America | $165.67 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $149.41 | 2020-2023 | Lynparza |
| Axonics, INC. | $149.07 | 2020 | |
| Agiliti Surgical, INC. | $137.91 | 2019-2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Janssen Biotech, INC. | $128.00 | 2019-2024 | Akeega, Erleada |
| Sumitomo Pharma America, INC. | $101.73 | 2023-2025 | Orgovyx |
| Urogen Pharma, INC. | $94.26 | 2025 | |
| Verity Pharmaceuticals INC. | $93.84 | 2022-2023 | Trelstar |
| Edap Technomed INC | $78.00 | 2024 | |
| Ferring Pharmaceuticals INC. | $45.48 | 2019-2025 | Adstiladrin |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $34.81 | 2021-2025 | Provenge |
| Merck Sharp & Dohme LLC | $33.29 | 2024-2025 | Keytruda |
| Boston Scientific Corporation | $32.81 | 2023-2024 | Rezum Generator |
| Endo Pharmaceuticals INC. | $32.02 | 2022-2023 | Edex, Xiaflex, Aveed |
| 180 Medical, INC. | $30.33 | 2019 | |
| Antares Pharma, INC. | $30.16 | 2020 | |
| Allergan, INC. | $24.45 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $24.11 | 2019 | |
| Calyxo, INC. | $23.10 | 2025 | Cvac Aspiration System |
| Telix Pharmaceuticals | $20.82 | 2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $20.34 | 2025 | |
| Laborie Medical Technologies Corp. | $16.75 | 2024 | Urgent Pc Neuromodulation System |
| Myovant Sciences INC. | $15.24 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.33 | 2024 | |
| Amgen INC. | $13.06 | 2020 | |
| Coloplast Corp | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Leu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.